Company
T2D.com
T2D.com publishes compounded semaglutide and unspecified GLP-1, from $99 to $170 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from t2d.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to T2D.com
We earn nothing from this link. T2D.com has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Bring Your Own Prescription (BYOP)
first month, including the required fees on record · Use Our Prescribers - Monthly, All-Inclusive
Terms
Not yet checked: pharmacy, membership, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. T2D.com never names the drug for its main 'Use Our Prescribers' plan on the pricing block (elsewhere the site says it offers compounded Semaglutide and Tirzepatide generally), so that $170/mo entry is recorded as unspecified GLP-1. Form (vial vs pen) is never stated. About-us and contact-us paths 404'd; /pricing, /faq and /plans also 404'd -- pricing lives at /weight-loss instead.
Before you act
Cite this
Treatment Registry. (2026). T2D.com: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/t2d